Connection

Frank Alexis to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Frank Alexis has written about Antineoplastic Agents.
Frank Alexis
Connection Strength
0.820
Antineoplastic Agents
  1. Nanotechnologies for noninvasive measurement of drug release. Mol Pharm. 2014 Jan 06; 11(1):24-39.
    View in: PubMed
    Score: 0.265
  2. Nanoparticle technologies for cancer therapy. Handb Exp Pharmacol. 2010; (197):55-86.
    View in: PubMed
    Score: 0.202
  3. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy. ChemMedChem. 2008 Dec; 3(12):1839-43.
    View in: PubMed
    Score: 0.188
  4. Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines. Artif Cells Nanomed Biotechnol. 2020 Dec; 48(1):1214-1221.
    View in: PubMed
    Score: 0.108
  5. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem. 2008 Sep; 3(9):1311-5.
    View in: PubMed
    Score: 0.046
  6. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem. 2007 Sep; 2(9):1268-71.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.